Home / Latest Reports / Zika Virus Testing Market

Zika Virus Testing Market By Test Type (Serological Testing and Nucleic Acid Amplification Testing (NAAT)) - Global Industry Analysis And Forecast To 2027

Published On : August 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC081226

SEGMENTS & REGIONS:

  • By Test Type: Serological Testing and Nucleic Acid Amplification Testing (NAAT
  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Industry Outlook

Zika is a flavivirus causes a sickness transmitted due to Ades mosquitoes. It can likewise be exchanged from one individual then onto the next by sexual contact or from the mother to the embryo amid pregnancy. Indications of the disease incorporate fatigue, headache, fever, nausea, and rash. Currently, no curative treatment is accessible for the Zika virus disease. Just palliative care is accessible to lighten the indications. In 2017, the World Health Organization (WHO) evaluated that the infection has been transmitted to 20 nations and regions crosswise over Americas. The detection kits of Zika virus at present accessible in the market are units for subjective tests that distinguish RNA of the Zika infection from the body tests, for example, plasma, urine, and serum.

Market Segmentation

The Zika Virus Testing Market is based on different segments namely by test type into Serological Testing and Nucleic Acid Amplification Testing (NAAT).

  • Zika Virus Testing Market By Test Type
    • Serological Testing
    • Nucleic Acid Amplification Testing (NAAT)

Regional Insights

On a global front, the Zika Virus Testing Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). The U.S. states and territories commanded the market in 2017. Since the flare-up, the U.S. has developed a national response framework to avert virus spread across the country by collaborating with companies, such as the CDC, WHO, and PAHO.

  • Zika Virus Testing Market, By Region
    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Quest Diagnostics, Altona Diagnostics, Biocan Diagnostics Inc, Euroimmun, Chembio Diagnostics and Roche Holding AG. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Quest Diagnostics
  • Altona Diagnostics
  • Biocan Diagnostics Inc
  • Euroimmun
  • Chembio Diagnostics
  • Roche Holding AG

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Zika Virus Testing Market, By Test Type, Estimates and Forecast, 2017-2027 ($Million)

·         Serological Testing and

·         Nucleic Acid Amplification Testing (NAAT)

·         Zika Virus Testing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

·         North America

§  North America Zika Virus Testing Market, By Country

o    U.S. Zika Virus Testing Market

o    Canada Zika Virus Testing Market

o    Mexico Zika Virus Testing Market

·         Europe

§  Europe Zika Virus Testing Market, By Country

o    Germany Zika Virus Testing Market

o    UK Zika Virus Testing Market

o    France Zika Virus Testing Market

o    Russia Zika Virus Testing Market

o    Italy Zika Virus Testing Market

o    Rest of Europe Zika Virus Testing Market

·         Asia-Pacific

§  Asia-Pacific Zika Virus Testing Market, By Country

o    China Zika Virus Testing Market

o    Japan Zika Virus Testing Market

o    South Korea Zika Virus Testing Market

o    India Zika Virus Testing Market

o    Southeast Asia Zika Virus Testing Market

o    Rest of Asia-Pacific Zika Virus Testing Market

·         South America

§  South America Zika Virus Testing Market

o    Brazil Zika Virus Testing Market

o    Argentina Zika Virus Testing Market

o    Columbia Zika Virus Testing Market

o    Rest of South America Zika Virus Testing Market

·         Middle East and Africa

§  Middle East and Africa Zika Virus Testing Market

o    Saudi Arabia Zika Virus Testing Market

o    UAE Zika Virus Testing Market

o    Egypt Zika Virus Testing Market

o    Nigeria Zika Virus Testing Market

o    South Africa Zika Virus Testing Market

o    Rest of MEA Zika Virus Testing Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2027)

4.1.2.  Canada Market States and Outlook (2017-2027)

4.1.3.  Mexico Market States and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2027)

4.2.2.  France Market States and Outlook (2017-2027)

4.2.3.  UK Market States and Outlook (2017-2027)

4.2.4.  Russia Market States and Outlook (2017-2027)

4.2.5.  Italy Market States and Outlook (2017-2027)

4.2.6.  Rest of Europe Market States and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2027)

4.3.2.  Japan Market States and Outlook (2017-2027)

4.3.3.  Korea Market States and Outlook (2017-2027)

4.3.4.  India Market States and Outlook (2017-2027)

4.3.5.  Southeast Asia Market States and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2027)

4.4.2.  Argentina Market States and Outlook (2017-2027)

4.4.3.  Columbia Market States and Outlook (2017-2027)

4.4.4.  Rest of South America Market States and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market States and Outlook (2017-2027)

4.5.3.  Egypt Market States and Outlook (2017-2027)

4.5.4.  Nigeria Market States and Outlook (2017-2027)

4.5.5.  South Africa Market States and Outlook (2017-2027)

4.5.6.  Turkey Market States and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market States and Outlook (2017-2027)

5.       Zika Virus Testing Market, By Test Type

5.1.     Introduction

5.2.     Global Zika Virus Testing Revenue and Market Share by Test Type (2017-2027)

5.2.1.  Global Zika Virus Testing Revenue and Revenue Share by Test Type (2017-2027)

5.3.     Serological Testing

5.3.1.  Global Serological Testing  Revenue and Growth Rate (2017-2027)

5.4.     Nucleic Acid Amplification Testing (NAAT)

5.4.1.  Global Nucleic Acid Amplification Testing (NAAT) Revenue and Growth Rate (2017-2027)

6.       Zika Virus Testing Market, By Region

6.1.     Introduction

6.2.     Global Zika Virus Testing Revenue and Market Share by Regions

6.2.1.  Global Zika Virus Testing Revenue by Regions (2017-2027)

6.3.     North America Zika Virus Testing by Countries

6.3.1.  North America Zika Virus Testing Revenue and Growth Rate (2017-2027)

6.3.2.  North America Zika Virus Testing Revenue (Million USD) by Countries (2017-2027)

6.3.3.  United States

6.3.3.1.  United States Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.4.  Canada

6.3.4.1.  Canada Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.5.  Mexico

6.3.5.1.  Mexico Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.     Europe Zika Virus Testing by Countries

6.4.1.  Europe Zika Virus Testing Revenue and Growth Rate (2017-2027)

6.4.2.  Europe Zika Virus Testing Revenue (Million USD) by Countries (2017-2027)

6.4.3.  Germany

6.4.3.1.  Germany Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.4.  France

6.4.4.1.  France Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.5.  UK

6.4.5.1.  UK Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.6.  Russia

6.4.6.1.  Russia Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.7.  Italy

6.4.7.1.  Italy Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.8.  Rest of Europe

6.4.8.1.  Rest of Europe Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.     Asia-Pacific Zika Virus Testing by Countries

6.5.1.  Asia-Pacific Zika Virus Testing Revenue and Growth Rate (2017-2027)

6.5.2.  Asia-Pacific Zika Virus Testing Revenue (Million USD) by Countries (2017-2027)

6.5.3.  China

6.5.3.1.  China Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.4.  Japan

6.5.4.1.  Japan Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.5.  Korea

6.5.5.1.  Korea Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.6.  India

6.5.6.1.  India Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.7.  Southeast Asia

6.5.7.1.  Southeast Asia Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.8.  Rest of Asia-Pacific

6.5.8.1.  Rest of Asia-Pacific Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.     South America Zika Virus Testing by Countries

6.6.1.  South America Zika Virus Testing Revenue and Growth Rate (2017-2027)

6.6.2.  South America Zika Virus Testing Revenue (Million USD) by Countries (2017-2027)

6.6.3.  Brazil

6.6.3.1.  Brazil Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.4.  Argentina

6.6.4.1.  Argentina Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.5.  Columbia

6.6.5.1.  Columbia Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.6.  Rest of South America

6.6.6.1.  Rest of South America Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.     Middle East and Africa Zika Virus Testing by Countries

6.7.1.  Middle East and Africa Zika Virus Testing Revenue and Growth Rate (2017-2027)

6.7.2.  Middle East and Africa Zika Virus Testing Revenue (Million USD) by Countries (2017-2027)

6.7.3.  Saudi Arabia

6.7.3.1.  Saudi Arabia Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.4.  United Arab Emirates

6.7.4.1.  United Arab Emirates Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.5.  Egypt

6.7.5.1.  Egypt Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.6.  Nigeria

6.7.6.1.  Nigeria Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.7.  South Africa

6.7.7.1.  South Africa Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.8.  Turkey

6.7.8.1.  Turkey Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.9.  Rest of Middle East and Africa

6.7.9.1.  Rest of Middle East and Africa Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.       Company Profiles

7.1.     Quest Diagnostics

7.1.1.  Business Overview

7.1.2.   Service Portfolio

7.1.3.  Strategic Developments

7.1.4.   Revenue and Market Share

7.2.     Altona Diagnostics

7.2.1.  Business Overview

7.2.2.   Service Portfolio

7.2.3.  Strategic Developments

7.2.4.   Revenue and Market Share

7.3.     Biocan Diagnostics Inc

7.3.1.  Business Overview

7.3.2.   Service Portfolio

7.3.3.  Strategic Developments

7.3.4.   Revenue and Market Share

7.4.     Euroimmun

7.4.1.  Business Overview

7.4.2.   Service Portfolio

7.4.3.  Strategic Developments

7.4.4.   Revenue and Market Share

7.5.     Chembio Diagnostics

7.5.1.  Business Overview

7.5.2.   Service Portfolio

7.5.3.  Strategic Developments

7.5.4.   Revenue and Market Share

7.6.     Roche Holding AG

7.6.1.  Business Overview

7.6.2.   Service Portfolio

7.6.3.  Strategic Developments

7.6.4.   Revenue and Market Share

8.       Global Zika Virus Testing Market Competition, by Manufacturer

8.1.     Global Zika Virus Testing Revenue and Market Share by Manufacturer (2017-2017)

8.2.     Global Zika Virus Testing Price By Region (2017-2017)

8.3.     Top 5 Zika Virus Testing Manufacturer Market Share

8.4.     Market Competition Trend

9.       Zika Virus Testing Market Forecast (2017-2027)

9.1.     Global Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     Zika Virus Testing Market Forecast by Regions (2017-2027)

9.2.1.  North America Zika Virus Testing Market Forecast (2017-2027)

9.2.1.1.  United States Zika Virus Testing Market Forecast (2017-2027)

9.2.1.2.  Canada Zika Virus Testing Market Forecast (2017-2027)

9.2.1.3.  Mexico Zika Virus Testing Market Forecast (2017-2027)

9.2.2.  Europe Zika Virus Testing Market Forecast (2017-2027)

9.2.2.1.  Germany Zika Virus Testing Market Forecast (2017-2027)

9.2.2.2.  France Zika Virus Testing Market Forecast (2017-2027)

9.2.2.3.  UK Zika Virus Testing Market Forecast (2017-2027)

9.2.2.4.  Russia Zika Virus Testing Market Forecast (2017-2027)

9.2.2.5.  Italy Zika Virus Testing Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe Zika Virus Testing Market Forecast (2017-2027)

9.2.3.  Asia-Pacific Zika Virus Testing Market Forecast (2017-2027)

9.2.3.1.  China Zika Virus Testing Market Forecast (2017-2027)

9.2.3.2.  Japan Zika Virus Testing Market Forecast (2017-2027)

9.2.3.3.  Korea Zika Virus Testing Market Forecast (2017-2027)

9.2.3.4.  India Zika Virus Testing Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia Zika Virus Testing Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific Zika Virus Testing Market Forecast (2017-2027)

9.2.4.  South America Zika Virus Testing Market Forecast (2017-2027)

9.2.4.1.  Brazil Zika Virus Testing Market Forecast (2017-2027)

9.2.4.2.  Argentina Zika Virus Testing Market Forecast (2017-2027)

9.2.4.3.  Columbia Zika Virus Testing Market Forecast (2017-2027)

9.2.4.4.  Rest of South America Zika Virus Testing Market Forecast (2017-2027)

9.2.5.  Middle East and Africa Zika Virus Testing Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia Zika Virus Testing Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates Zika Virus Testing Market Forecast (2017-2027)

9.2.5.3.  Egypt Zika Virus Testing Market Forecast (2017-2027)

9.2.5.4.  Nigeria Zika Virus Testing Market Forecast (2017-2027)

9.2.5.5.  South Africa Zika Virus Testing Market Forecast (2017-2027)

9.2.5.6.  Turkey Zika Virus Testing Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa Zika Virus Testing Market Forecast (2017-2027)

9.3.     Zika Virus Testing Market Forecast by Test Type (2017-2027)

9.3.1.  Zika Virus Testing Forecast by Test Type (2017-2027)

9.3.2.  Zika Virus Testing Market Share Forecast by Test Type (2017-2027)

List of Tables

10. List of Tables and Figures
Figure United States Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Zika Virus Testing Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Zika Virus Testing Revenue and Revenue Share by Test Type (2017-2018)
Figure Global Serological Testing Revenue and Growth Rate (2017-2018)
Figure Global Nucleic Acid Amplification Testing (NAAT) Revenue and Growth Rate (2017-2018)
Table Global Zika Virus Testing Revenue by Regions (2017-2018)
Figure North America Zika Virus Testing Growth Rate (2017-2018)
Figure North America Zika Virus Testing Revenue and Growth Rate (2017-2018)
Figure North America Zika Virus Testing by Countries (2017-2018)
Figure North America Zika Virus Testing Revenue (Million USD) by Countries (2017-2018)
Figure United States Zika Virus Testing Growth Rate (2017-2018)
Figure United States Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Zika Virus Testing Growth Rate (2017-2018)
Figure Canada Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Zika Virus Testing Growth Rate (2017-2018)
Figure Mexico Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Zika Virus Testing Growth Rate (2017-2018)
Figure Europe Zika Virus Testing Revenue and Growth Rate (2017-2018)
Figure Europe Zika Virus Testing by Countries (2017-2018)
Figure Europe Zika Virus Testing Revenue (Million USD) by Countries (2017-2018)
Figure Germany Zika Virus Testing Growth Rate (2017-2018)
Figure Germany Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Zika Virus Testing Growth Rate (2017-2018)
Figure France Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Zika Virus Testing Growth Rate (2017-2018)
Figure UK Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Zika Virus Testing Growth Rate (2017-2018)
Figure Russia Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Zika Virus Testing Growth Rate (2017-2018)
Figure Italy Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Zika Virus Testing Growth Rate (2017-2018)
Figure Rest of Europe Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Zika Virus Testing Growth Rate (2017-2018)
Figure Asia-Pacific Zika Virus Testing Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Zika Virus Testing by Countries (2017-2018)
Figure Asia-Pacific Zika Virus Testing Revenue (Million USD) by Countries (2017-2018)
Figure China Zika Virus Testing Growth Rate (2017-2018)
Figure China Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Zika Virus Testing Growth Rate (2017-2018)
Figure Japan Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Zika Virus Testing Growth Rate (2017-2018)
Figure Korea Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Zika Virus Testing Growth Rate (2017-2018)
Figure India Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Zika Virus Testing Growth Rate (2017-2018)
Figure Southeast Asia Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Zika Virus Testing Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Zika Virus Testing Growth Rate (2017-2018)
Figure South America Zika Virus Testing Revenue and Growth Rate (2017-2018)
Figure South America Zika Virus Testing by Countries (2017-2018)
Figure South America Zika Virus Testing Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Zika Virus Testing Growth Rate (2017-2018)
Figure Brazil Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Zika Virus Testing Growth Rate (2017-2018)
Figure Argentina Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Zika Virus Testing Growth Rate (2017-2018)
Figure Columbia Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Zika Virus Testing Growth Rate (2017-2018)
Figure Rest of South America Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Zika Virus Testing Growth Rate (2017-2018)
Figure Middle East and Africa Zika Virus Testing Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Zika Virus Testing by Countries (2017-2018)
Figure Middle East and Africa Zika Virus Testing Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Zika Virus Testing Growth Rate (2017-2018)
Figure Saudi Arabia Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Zika Virus Testing Growth Rate (2017-2018)
Figure United Arab Emirates Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Zika Virus Testing Growth Rate (2017-2018)
Figure Egypt Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Zika Virus Testing Growth Rate (2017-2018)
Figure Nigeria Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Zika Virus Testing Growth Rate (2017-2018)
Figure South Africa Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Zika Virus Testing Growth Rate (2017-2018)
Figure Turkey Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Zika Virus Testing Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Zika Virus Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Table Quest Diagnostics Zika Virus Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Altona Diagnostics Zika Virus Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Biocan Diagnostics Inc Zika Virus Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Euroimmun Zika Virus Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Chembio Diagnostics Zika Virus Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Roche Holding AG Zika Virus Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Zika Virus Testing Market Share by Manufacturer
Figure Global Zika Virus Testing Revenue and Market Share by Manufacturer
Table Global Zika Virus Testing Price by Region (2017-2017)
Figure Top 5 Zika Virus Testing Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Zika Virus Testing Revenue (Millions USD) and Growth Rate (2018-2025)
Table Zika Virus Testing Market Forecast by Regions (2018-2025)
Figure North America Zika Virus Testing Market Forecast (2018-2025)
Figure United States Zika Virus Testing Market Forecast (2018-2025)
Figure Canada Zika Virus Testing Market Forecast (2018-2025)
Figure Mexico Zika Virus Testing Market Forecast (2018-2025)
Figure Europe Zika Virus Testing Market Forecast (2018-2025)
Figure Germany Zika Virus Testing Market Forecast (2018-2025)
Figure France Zika Virus Testing Market Forecast (2018-2025)
Figure UK Zika Virus Testing Market Forecast (2018-2025)
Figure Russia Zika Virus Testing Market Forecast (2018-2025)
Figure Italy Zika Virus Testing Market Forecast (2018-2025)
Figure Rest of Europe Zika Virus Testing Market Forecast (2018-2025)
Figure Asia-Pacific Zika Virus Testing Market Forecast (2018-2025)
Figure China Zika Virus Testing Market Forecast (2018-2025)
Figure Japan Zika Virus Testing Market Forecast (2018-2025)
Figure Korea Zika Virus Testing Market Forecast (2018-2025)
Figure India Zika Virus Testing Market Forecast (2018-2025)
Figure Southeast Asia Zika Virus Testing Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Zika Virus Testing Market Forecast (2018-2025)
Figure South America Zika Virus Testing Market Forecast (2018-2025)
Figure Brazil Zika Virus Testing Market Forecast (2018-2025)
Figure Argentina Zika Virus Testing Market Forecast (2018-2025)
Figure Columbia Zika Virus Testing Market Forecast (2018-2025)
Figure Rest of South America Zika Virus Testing Market Forecast (2018-2025)
Figure Middle East and Africa Zika Virus Testing Market Forecast (2018-2025)
Figure Saudi Arabia Zika Virus Testing Market Forecast (2018-2025)
Figure United Arab Emirates Zika Virus Testing Market Forecast (2018-2025)
Figure Egypt Zika Virus Testing Market Forecast (2018-2025)
Figure Nigeria Zika Virus Testing Market Forecast (2018-2025)
Figure South Africa Zika Virus Testing Market Forecast (2018-2025)
Figure Turkey Zika Virus Testing Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Zika Virus Testing Market Forecast (2018-2025)
Figure Global Zika Virus Testing Forecast by Test Type (2018-2025)
Figure Global Zika Virus Testing Market Share Forecast by Test Type (2018-2025)
Figure Global Zika Virus Testing Forecast by Test Type (2018-2025)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample